Su1561 CLINICAL CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI). INSIGHT FROM THE NATIONAL INPATIENT SAMPLE.
Aboursheid T, Hijazi M, Albuni M, Sawaf B, Khokhlov L, Elfert K, Beran A, Abdalla M, Chaar A. Su1561 CLINICAL CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI). INSIGHT FROM THE NATIONAL INPATIENT SAMPLE. Gastroenterology 2024, 166: s-1640. DOI: 10.1016/s0016-5085(24)04230-6.Peer-Reviewed Original Research